The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-β1) levels in normal healthy blood donors

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 476-481

  Young, D G ^a   Skibinski, G ^a   Mason, J I ^a   James, K ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Ageing; Dehydroepiandrosterone sulphate; IL 6; IL 6 soluble receptor; Transforming growth factor beta

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PRASTERONE SULFATE; TRANSFORMING GROWTH FACTOR BETA;

AGE; ARTICLE; GENDER; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGING; BLOOD DONORS; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6; REFERENCE VALUES; SEX CHARACTERISTICS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0001090139     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01003.x     Document Type: Article

References (45)

1. 1 Pawelec G, Adibzadeh M, Pohla H, Schaudt K. Immunosenescence: ageing of the immune system. Immunol Today 1995; 16:420-2.
2. 2 Burns EA, Goodwin JS. Immunodeficiency of aging. Drugs Aging 1997; 11:374-97.
3. 3 Candore G, Di Lorenzo G, Melluso M, Cigna D, Colucci AT, Modica MA, Caruso C. γ-Interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. Autoimmunity 1993; 16:275-80.
4. 2 T cell subpopulations in the elderly. Mech Ageing Dev 1996; 87:197-209.
5. 5 Caruso C, Candore G, Cigna D, Di Lorenzo G, Sireci G, Dieli F, Salerno A. Cytokine production pathway in the elderly. Immunol Res 1996; 15:84-90.
6. 6 Spencer NFL, Norton SD, Harrison LL, Li GZ, Daynes RA. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 1996; 31:393-408.
7. 7 Gillis S, Kozak R, Durante M, Weksler ME. Immunological studies of aging: decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981; 67:937-42.
8. 8 Mysliwska J, Bryl E, Foerster J, Mysliwski A. Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by health status. Mech Ageing Dev 1998; 100:313-28.
9. 9 Wei J, Xu H, Davies JL, Heminings GP. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 1992; 51:1953-6.
10. 10 Ershler WB. Interleukin-6: a cytokine for gerentologists. J Am Geriatr Soc 1993; 41:176-81.
11. 11 Ershler WB, Sun WH, Binkley N et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 1991; 12:225-30.
12. 12 Fagiolo U, Cossarizza A, Scala E et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993; 23:2375-8.
13. 13 Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J, Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 1994; 15:771-2.
14. 14 Dasgupta B, Corkill M, Kirkham B, Gibson T, Panayi G. Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol 1992; 19:22-25.
15. 15 Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. N Engl J Med 1995; 332:305-11.
16. 16 Ikeda U, Ikeda M, Seino Y, Takahashi M, Kuno S, Shimada K. Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits. Atherosclerosis 1992; 92:213-8.
17. 17 Vandenabeele P, Fiers W. Is amyloidogenesis during Alzheimer's disease due to an lL-1-/IL-6-mediated 'acute phase response' in the brain? Immunol Today 1991; 12:217-9.
18. 18 Wood JA, Wood PL, Ryan R, Graff-Radford NR, Pilapil C, Robitaille V, Quirion R, Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. Brain Res 1993; 629:245-52.
19. 19 Kawano M, Hirano T, Matsuda T et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332:83-85.
20. 20 Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. J Immunol 1993; 150:5219-30.
21. 21 James K, Premehand N, Skibinska A, Skibinski G, Nicol M, Mason JI. IL-6, DHEA and the ageing process. Mech Ageing Dev 1997; 93:15-24.
22. 22 Reed MJ. The discriminant-function test: a marker of Th1/Th2 cell cytokine secretion and breast tumour oestrogen synthesis. Mol Med Today 1995; 1:98-103.
23. 23 Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, Falk W, Lang B. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro. possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998; 83:2012-7.
24. 24 Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59:551-5.
25. 25 Bélanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 1994; 79:1086-90.
26. 26 Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82:2396-402.
27. 27 Sulcová J, Hill M, Hampl R, Stárka L. Age and sex related differences in serum levels of unconjugatcd dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 1997; 154:57-62.
28. 14 in young and elderly men. 1. Secretion rate of cortisol and daily excretion of tetrahydrocortisol, allotetrahydrocortisol, tetrahydrocortisone and cortolone (20α and 20β). J Clin Endocrinol Metab 1961; 21:1413-25.
29. 29 Daynes RA, Araneo BA. Prevention and reversal of some age-assocated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging Immunol Infect Dis 1992; 3:135-54.
30. 30 Casson PR, Andersen RN, Herrod HG, Stentz FB, Straughn AB, Abraham GE, Buster JE. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 1993; 169:1536-9.
31. 31 Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women: potential remedial effects. Ann NY Acad Sci 1995; 774:128-42.
32. 32 Khorram O. DHEA: a hormone with multiple effects, Curr Opin Obs Gynecol 1996; 8:351-4.
33. 33 Watson RR, Huls A, Araghinikuam M, Chung S. Dehydroepiandrosterone and diseases of aging. Drugs Aging 1996; 9:274-91.
34. 34 Khorram O, Vu L, Yen SC. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol 1997; 52A:M1-M7.
35. 35 Peterson PK, Chao CC, Carson P, Hu S, Nichol K, Janoff EN. Levels of tumor necrosis factor α, interleukin 6, interleukin 10, and transforming growth factor β are normal in the serum of the healthy elderly. Clin Infect Dis 1994; 19:1158-9.
36. 36 Müller-Newen G, Küster A, Hemmann U et al. Soluble 1L-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J Immunol 1998; 161:6347-55.
37. 37 Wu MF, Chang HL, Tseng J. Dehydroepiandrosterone induces the transforming growth factor-β production by murine macrophages. Int J Tiss Reac 1997:141-8.
38. 38 Wagstaff W. Guidelines for the Blood Transfusion Services in the United Kingdom, 3rd edn. Watford: National Blood Service, 1996.
39. 39 Babson AL. The Cirrus Immulite automated immunoassay system. J Clin Immunoassay 1991; 14:83-88.
40. 40 Babson AL, Olson DR, Palmieri T, Ross AF, Becker DM, Mulqueen PJ. The Immulite assay tube: a new approach to heterogeneous ligand assay. Clin Chem 1991; 37:1521-2.
41. 41 Rosenfeld RS, Hellman L, Gallagher TF. Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 1972; 35:187-93.
42. 42 Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol 1996; 150:S125-S127.
43. 43 Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992; 75:1002-4.
44. 44 Zumoff B, Bradlow HL. Sex differences in the metabolism of dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 1980; 51:334-6.
45. 45 Cohen HJ, Pieper CF, Harris T, Rao KMK, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol: Med Sci 1997; 52A:M201-M208.